TY - JOUR
TI - Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
AU - Jalink, M.
AU - Berentsen, S.
AU - Castillo, J.J.
AU - Treon, S.P.
AU - Cruijsen, M.
AU - Fattizzo, B.
AU - Cassin, R.
AU - Fotiou, D.
AU - Kastritis, E.
AU - De Haas, M.
AU - Oosten, L.E.M.
AU - Frederiksen, H.
AU - Patriarca, A.
AU - D'Sa, S.
AU - Vos, J.M.I.
JO - Blood advances
PY - 2021
VL - 138
TODO - 20
SP - 2002-2005
PB - Elsevier B.V.
SN - null
TODO - 10.1182/blood.2021012039
TODO - bendamustine;  bortezomib;  Bruton tyrosine kinase inhibitor;  chlorambucil;  cyclophosphamide;  dexamethasone;  fludarabine;  granulocyte colony stimulating factor;  hemoglobin;  ibrutinib;  immunoglobulin;  lactate dehydrogenase;  mycophenolate mofetil;  myeloid differentiation factor 88;  obinutuzumab;  rituximab;  steroid;  adenine;  BTK protein, human;  ibrutinib;  piperidine derivative;  protein kinase inhibitor, acrocyanosis;  aged;  autoimmune hemolytic anemia;  blood level;  chronic lymphatic leukemia;  clinical article;  clinical study;  contusion;  diarrhea;  drug efficacy;  drug substitution;  drug withdrawal;  female;  follow up;  gene mutation;  hemoglobin blood level;  hemolytic anemia;  human;  information processing;  Letter;  lymphocytic lymphoma;  male;  medical parameters;  multiple cycle treatment;  neutropenia;  plasmapheresis;  questionnaire;  rash;  retrospective study;  Waldenstroem macroglobulinemia;  autoimmune hemolytic anemia;  complication;  cyanosis;  middle aged;  very elderly, Adenine;  Agammaglobulinaemia Tyrosine Kinase;  Aged;  Aged, 80 and over;  Anemia, Hemolytic, Autoimmune;  Cyanosis;  Female;  Humans;  Male;  Middle Aged;  Piperidines;  Protein Kinase Inhibitors;  Retrospective Studies
TODO - null
ER -